Treatment of ARDS.
Improved understanding of the pathogenesis of acute lung injury (ALI)/ARDS has led to important advances in the treatment of ALI/ARDS, particularly in the area of ventilator-associated lung injury. Standard supportive care for ALI/ARDS should now include a protective ventilatory strategy with low tidal volume ventilation by the protocol developed by the National Institutes of Health ARDS Network. Further refinements of the protocol for mechanical ventilation will occur as current and future clinical trials are completed. In addition, novel modes of mechanical ventilation are being studied and may augment standard therapy in the future. Although results of anti-inflammatory strategies have been disappointing in clinical trials, further trials are underway to test the efficacy of late corticosteroids and other approaches to modulation of inflammation in ALI/ARDS.
Brower
R G
RG
Johns Hopkins University, Baltimore, MD, USA.
Ware
L B
LB
Berthiaume
Y
Y
Matthay
M A
MA
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003422:Critical Care / Q000379:methods; D019091:Critical Pathways; D006801:Humans; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D013256:Steroids; D015996:Survival Rate
D000893:Anti-Inflammatory Agents; D013256:Steroids